Cargando…
Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease
Various amyloidogenic proteins have been suggested to be involved in the onset and progression of neurodegenerative diseases (ND) such as Alzheimer's disease (AD) and Parkinson's disease (PD). Particularly, the aggregation of misfolded amyloid-β and hyperphosphorylated tau and α-synuclein...
Autores principales: | Kim, Namdoo, Lee, Hyuck Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7669341/ https://www.ncbi.nlm.nih.gov/pubmed/33224974 http://dx.doi.org/10.1155/2020/2010728 |
Ejemplares similares
-
Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease
por: Kim, Namdoo, et al.
Publicado: (2021) -
Metal Complexes as Promising Matrix Metalloproteinases Regulators
por: Nguyen, Yen Thi, et al.
Publicado: (2023) -
Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer’s Disease
por: Wang, Shanshan, et al.
Publicado: (2022) -
Current Opinion on the Role of Neurogenesis in the Therapeutic Strategies for Alzheimer Disease, Parkinson Disease, and Ischemic Stroke; Considering Neuronal Voiding Function
por: Han, Myung-Hoon, et al.
Publicado: (2016) -
Novel Approaches for the Treatment of Alzheimer’s and Parkinson’s Disease
por: Van Bulck, Michiel, et al.
Publicado: (2019)